Brightmedex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 1.30%
- Ebitda
- Net Worth -0.91%
- Total Assets -14.23%
About Brightmedex
Brightmedex Private Limited (BPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2012 and has a history of 12 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Brightmedex Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Abdulbari and Rehana Begum serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2012PTC079549
-
Company No.
079549
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Brightmedex Private Limited offer?
Brightmedex Private Limited offers a wide range of products and services, including Herbs,Sticks and Roots, Psyllium Husk, Rapid Test Kit, Diagnostic Test Kit, Medical Consultants & Clinics, Hair Treatment, Pharmaceutical Machinery & Equipment, Capsule Filling Machines, Metal & Metal Made Products, Nano Powder.
Who are the key members and board of directors at Brightmedex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Abdulbari
|
Director | 07-Aug-2024 | Current |
|
Rehana Begum
|
Director | 20-Aug-2022 | Current |
Financial Performance of Brightmedex.
Brightmedex Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.3% increase in profit. The company's net worth dipped by a decrease of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brightmedex?
In 2020, Brightmedex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Brightmedex?
Unlock and access historical data on people associated with Brightmedex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brightmedex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brightmedex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
